AllianceBernstein’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.5M Buy
4,754,671
+4,034,159
+560% +$48.2M 0.01% 798
2026
Q1
$5.17M Buy
720,512
+589,628
+450% +$4.44M ﹤0.01% 1526
2025
Q4
$938K Sell
130,884
-301,368
-70% -$2.38M ﹤0.01% 2376
2025
Q3
$4.62M Buy
432,252
+21,372
+5% +$210K ﹤0.01% 1553
2025
Q2
$3.98M Buy
410,880
+321,225
+358% +$3.31M ﹤0.01% 1582
2025
Q1
$1.33M Sell
89,655
-60,114
-40% -$924K ﹤0.01% 2101
2024
Q4
$2.23M Buy
149,769
+11,075
+8% +$180K ﹤0.01% 1898
2024
Q3
$2.65M Sell
138,694
-44,628
-24% -$925K ﹤0.01% 1824
2024
Q2
$3.79M Buy
183,322
+38,635
+27% +$768K ﹤0.01% 1607
2024
Q1
$2.72M Sell
144,687
-25,845
-15% -$444K ﹤0.01% 1753
2023
Q4
$2.46M Sell
170,532
-148,640
-47% -$2.02M ﹤0.01% 1827
2023
Q3
$5.54M Buy
319,172
+6,907
+2% +$144K ﹤0.01% 1371
2023
Q2
$6.5M Sell
312,265
-13,161
-4% -$286K ﹤0.01% 1327
2023
Q1
$7.65M Buy
325,426
+18,744
+6% +$503K ﹤0.01% 1213
2022
Q4
$8.57M Sell
306,682
-199,627
-39% -$5.1M ﹤0.01% 1179
2022
Q3
$11.8M Sell
506,309
-11,542
-2% -$348K 0.01% 1011
2022
Q2
$17.5M Buy
517,851
+413
+0.1% +$14.5K 0.01% 910
2022
Q1
$18.1M Sell
517,438
-424,324
-45% -$14.5M 0.01% 967
2021
Q4
$28.7M Buy
941,762
+199,190
+27% +$6.49M 0.01% 816
2021
Q3
$24.3M Buy
742,572
+185,349
+33% +$5.93M 0.01% 868
2021
Q2
$16.9M Buy
+557,223
New +$18.3M 0.01% 1012

Other funds holding OGN

AllianceBernstein's OGN Position: Q2 2026 in Review

AllianceBernstein increased its Organon & Co (OGN) stake by 560% in Q2 2026, buying an estimated $48.2M and bringing the position to 4,754,671 shares worth $28.5M. The position accounts for 0.01% of the portfolio, ranked #798.

AllianceBernstein first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $28.7M in Q4 2021. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • AllianceBernstein held 4,754,671 shares of Organon & Co worth $28.5M as of Q2 2026.
  • AllianceBernstein bought 4,034,159 Organon & Co shares in Q2 2026, an estimated $48.2M.
  • Organon & Co made up 0.01% of AllianceBernstein's portfolio in Q2 2026, its #798 holding.
  • AllianceBernstein first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • AllianceBernstein's Organon & Co position peaked at $28.7M in Q4 2021.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.